OncoTherapy Science, Inc. (TYO:4564)
Japan · Delayed Price · Currency is JPY 21.00
0.00 (0.00%)
May 12, 2026, 3:30 PM JST
OncoTherapy Science Market Cap
OncoTherapy Science has a market cap or net worth of 8.06 billion as of May 12, 2026. Its market cap has increased by 28.95% in one year.
Market Cap
8.06B
Enterprise Value
5.97B
Revenue
808.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
21.00
Market Cap Chart
Since June 29, 2007, OncoTherapy Science's market cap has decreased from 13.84B to 8.06B, a decrease of -41.80%. That is a compound annual growth rate of -2.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 8.06B | 17.22% |
| Dec 30, 2025 | 6.87B | 1.20% |
| Dec 30, 2024 | 6.79B | 35.66% |
| Dec 29, 2023 | 5.01B | -50.03% |
| Dec 30, 2022 | 10.02B | -27.78% |
| Dec 30, 2021 | 13.87B | -31.60% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kubota Pharmaceutical Holdings | 9.58B |
| Carna Biosciences | 9.02B |
| K Pharma,Inc. | 8.67B |
| MEDINET | 7.77B |
| Kohjin Bio | 7.57B |
| StemCell Institute | 7.53B |
| BrightPath Biotherapeutics | 7.30B |
| ADR120S | 7.25B |